133 related articles for article (PubMed ID: 15937215)
21. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
[TBL] [Abstract][Full Text] [Related]
22. Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors.
Pfaffendorf M; Batink HD; Tränkle C; Mohr K; van Zwieten PA
J Auton Pharmacol; 2000 Feb; 20(1):55-62. PubMed ID: 11048962
[TBL] [Abstract][Full Text] [Related]
23. Equipotent allosteric effect of W84 on [3H]NMS-binding to cardiac muscarinic receptors from guinea-pig, rat, and pig.
Mohr K; Staschen CM; Ziegenhagen M
Pharmacol Toxicol; 1992 Mar; 70(3):198-200. PubMed ID: 1579545
[TBL] [Abstract][Full Text] [Related]
24. Two-state models and the analysis of the allosteric effect of gallamine at the M2 muscarinic receptor.
Ehlert FJ; Griffin MT
J Pharmacol Exp Ther; 2008 Jun; 325(3):1039-60. PubMed ID: 18305010
[TBL] [Abstract][Full Text] [Related]
25. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
Krejcí A; Tucek S
Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
[TBL] [Abstract][Full Text] [Related]
26. Comparison of structurally different allosteric modulators of muscarinic receptors by self-organizing neural networks.
Holzgrabe U; Wagener M; Gasteiger J
J Mol Graph; 1996 Aug; 14(4):185-93, 217-21. PubMed ID: 9076632
[TBL] [Abstract][Full Text] [Related]
27. Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors.
Tränkle C; Dittmann A; Schulz U; Weyand O; Buller S; Jöhren K; Heller E; Birdsall NJ; Holzgrabe U; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2005 Dec; 68(6):1597-610. PubMed ID: 16157694
[TBL] [Abstract][Full Text] [Related]
28. Structure/activity relationships of M2 muscarinic allosteric modulators.
Mohr K; Tränkle C; Holzgrabe U
Recept Channels; 2003; 9(4):229-40. PubMed ID: 12893536
[TBL] [Abstract][Full Text] [Related]
29. Allosteric effects of the alkane-bis-ammonium compound W84 and of tacrine on [3H]pirenzepine binding at M1-receptors in rat cerebral cortex.
Mohr K; Tränkle C
Pharmacol Toxicol; 1994 Dec; 75(6):391-4. PubMed ID: 7899262
[TBL] [Abstract][Full Text] [Related]
30. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.
Redka DS; Pisterzi LF; Wells JW
Mol Pharmacol; 2008 Sep; 74(3):834-43. PubMed ID: 18552124
[TBL] [Abstract][Full Text] [Related]
31. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
Lanzafame A; Christopoulos A; Mitchelson F
J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
[TBL] [Abstract][Full Text] [Related]
32. Interaction of Mg2+ with the allosteric site of muscarinic M2 receptors.
Burgmer U; Schulz U; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):363-70. PubMed ID: 9606020
[TBL] [Abstract][Full Text] [Related]
33. Allosteric interactions at muscarinic cholinoceptors.
Christopoulos A; Lanzafame A; Mitchelson F
Clin Exp Pharmacol Physiol; 1998; 25(3-4):185-94. PubMed ID: 9590567
[TBL] [Abstract][Full Text] [Related]
34. Site-directed mutagenesis implicates a threonine residue in TM6 in the subtype selectivities of UH-AH 37 and pirenzepine at muscarinic receptors.
Ellis J; Seidenberg M
Pharmacology; 2000 Aug; 61(2):62-9. PubMed ID: 10940778
[TBL] [Abstract][Full Text] [Related]
35. Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.
Gregory KJ; Hall NE; Tobin AB; Sexton PM; Christopoulos A
J Biol Chem; 2010 Mar; 285(10):7459-74. PubMed ID: 20051519
[TBL] [Abstract][Full Text] [Related]
36. Mutagenesis of nucleophilic residues near the orthosteric binding pocket of M1 and M2 muscarinic receptors: effect on the binding of nitrogen mustard analogs of acetylcholine and McN-A-343.
Suga H; Sawyer GW; Ehlert FJ
Mol Pharmacol; 2010 Oct; 78(4):745-55. PubMed ID: 20643905
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of receptor/G protein coupling selectivity studied by coexpression of wild type and mutant m2 muscarinic receptors with mutant G alpha(q) subunits.
Kostenis E; Conklin BR; Wess J
Biochemistry; 1997 Feb; 36(6):1487-95. PubMed ID: 9063897
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease.
Hernandez CC; Nascimento JH; Chaves EA; Costa PC; Masuda MO; Kurtenbach E; Campos DE Carvalho AC; Gimenez LE
J Recept Signal Transduct Res; 2008; 28(4):375-401. PubMed ID: 18702010
[TBL] [Abstract][Full Text] [Related]
39. Development of a new type of allosteric modulator of muscarinic receptors: hybrids of the antagonist AF-DX 384 and the hexamethonio derivative W84.
Mohr M; Heller E; Ataie A; Mohr K; Holzgrabe U
J Med Chem; 2004 Jun; 47(12):3324-7. PubMed ID: 15163212
[TBL] [Abstract][Full Text] [Related]
40. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
